Novozymes (NVZMY)
(Delayed Data from OTC)
$68.66 USD
+0.98 (1.45%)
Updated Sep 20, 2024 03:59 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Novozymes AS falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 441.26 | 521.94 | 500.37 | 432.94 | 472.93 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -24.10 | -82.55 | -97.37 | 47.65 | -21.59 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 185.71 | 127.86 | 243.26 | 186.60 | 27.73 |
Net Cash From Operating Activities | 602.87 | 567.25 | 646.26 | 667.19 | 479.08 |
Property & Equipment | -269.20 | -386.85 | -150.67 | -121.03 | -128.31 |
Acquisition/ Disposition of Subsidiaries | -11.76 | 26.90 | -259.49 | -90.08 | 64.46 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -28.75 | -18.41 | -26.89 | -22.37 | -20.24 |
Net Cash from Investing Activities | -309.71 | -378.36 | -437.05 | -233.48 | -84.09 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 24.25 | -47.58 | -189.49 | -151.97 | -288.56 |
Issuance (Repayment) of Debt | 134.02 | 103.51 | 186.78 | 86.56 | 124.12 |
Increase (Decrease) Short-Term Debt | -17.86 | -16.99 | -16.39 | -17.01 | -16.19 |
Payment of Dividends & Other Distributions | -414.69 | -215.94 | -233.24 | -227.20 | -215.71 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -44.89 | 0.00 |
Net Cash from Financing Activities | -274.28 | -177.00 | -252.33 | -354.50 | -396.34 |
Effect of Exchange Rate Changes | -7.99 | -0.85 | 8.43 | -7.20 | -0.45 |
Net Change In Cash & Equivalents | 10.89 | 11.04 | -34.68 | 72.00 | -1.80 |
Cash at Beginning of Period | 151.15 | 136.36 | 187.90 | 108.93 | 108.38 |
Cash at End of Period | 162.04 | 147.41 | 153.21 | 180.93 | 106.58 |
Diluted Net EPS | 1.58 | 1.87 | 1.79 | 1.54 | 1.65 |
Fiscal Year End for Novozymes AS falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | 441.26 | 342.22 | 206.73 |
Depreciation/Amortization & Depletion | NA | NA | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | NA | NA | -24.10 | -86.58 | -118.63 |
Net Cash from Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | NA | 185.71 | 186.73 | 122.87 |
Net Cash From Operating Activities | NA | NA | 602.87 | 442.38 | 210.97 |
Property & Equipment | NA | NA | -269.20 | -199.58 | -135.87 |
Acquisition/ Disposition of Subsidiaries | NA | NA | -11.76 | -11.83 | -10.23 |
Investments | NA | NA | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | NA | -28.75 | -11.97 | -6.43 |
Net Cash from Investing Activities | NA | NA | -309.71 | -223.38 | -152.53 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 24.25 | 12.85 | 11.69 |
Issuance (Repayment) of Debt | NA | NA | 134.02 | 49.06 | 188.47 |
Increase (Decrease) Short-Term Debt | NA | NA | -17.86 | -13.87 | -9.35 |
Payment of Dividends & Other Distributions | NA | NA | -414.69 | -242.80 | -242.96 |
Other Financing Activities | NA | NA | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | NA | -274.28 | -194.76 | -52.16 |
Effect of Exchange Rate Changes | NA | NA | -7.99 | -4.67 | -5.26 |
Net Change In Cash & Equivalents | NA | NA | 10.89 | 19.56 | 1.02 |
Cash at Beginning of Period | NA | NA | 151.15 | 151.99 | 152.09 |
Cash at End of Period | NA | NA | 162.04 | 171.55 | 153.11 |
Diluted Net EPS | NA | NA | 0.36 | 0.49 | 0.32 |